ABSTRACT
Objective@#This study analyzes the development of school doctor personnel since the implementation of the national "School Health Work Regulations", from the salary of school doctors, followed by the management system of school doctors in primary and middle schools.@*Methods@#Representative provinces in the eastern, central and western regions of China were selected and surveyed through quantitative and qualitative method.@*Results@#The proportion of school doctors with medical background accounted for 33.64%, 31.6% school doctors had t o be established. A huge gap between income, bonus distribution and appraisal exsited between school doctors and school teachers. Wages of school doctors was much lower than that of education and social health sectors. The salary level showed regional imbalance, relatively higher in the eastern region and lower in the in the central and western regions with few exceptions. There were significant differences between medical background school doctors and non medical background school doctors in the highest educational background, income level, job nature, job placement, career development opportunity, income satisfaction, welfare and training satisfaction( χ 2=10.73,26.64,313.44,14.13,29.14,13.22,12.97,19.44, P < 0.05 ).@*Conclusion@#Government needs to pay attention to the school doctors in primary and secondary schools, integreate school health into public health management system. Relevant policies regarding school doctor management authority, school clinic and health center guideline, salary standards, as well as professional career development, are expected.
ABSTRACT
A new carbazole alkaloid was isolated from the aqueous extract of the stems of Clausena lansium (Lour.) Skeels by various chromatographic methods, including HPD-100, PRP-512A, silica gel, and reverse phase C18. Its structure was determined by spectroscopic and chemical methods, including UV, IR, HR-ESI-MS, 1D/2DNMR and ECD. Compound 1, named as Claulamine F, showed no antimicrobial activity on Staphylococcus aureus, Escherichia coli or Pseudomonas aeruginosa. In addition, compound 1 exhibited no cytotoxicity on five kinds of cancer cells through MTT methods.
ABSTRACT
Objective To analyse the cases of sudden death due to hyperthyroid heart disease,and explore the general information of deaths and the forensic pathological characteristics to provide reference evidence for forensic identification of such cases.Methods Six cases of sudden death due to hyperthyroid heart disease between 2001 and 2016 were selected from School of Forensic Medicine,China Medical University.The general information (gender and age),clinical manifestations,medical history,anatomical and histopathological findings,biochemical parameters and cause of death were analysed retrospectively.Results Most of the 6 patients had definite history of hyperthyroidism,and they all showed certain degrees of symptoms of cardiovascular disease;had obvious incentive factors of death;histopathological examination of thyroid conformed to the performances of diffuse toxic goiter;with increase of cardiac weight,dilatation of cardiac chambers,myocardial hypertrophy and focal necrosis;postmortem biochemical analyses of pericardial fluid could be used as an additional method for diagnostic of sudden death due to hyperthyroid heart disease.Conclusion The identification of death due to hyperthyroid heart disease should be based on the clinical history and the results of autopsy,histopathological examination,postmortem toxicology tests.The postmortem biochemical detection of thyroid and cardiac function should be performed if necessary.
ABSTRACT
<p><b>OBJECTIVE</b>To explore the diagnosis, treatment, and prognosis of prostatic malignant mesenchymal tumors (PMMT).</p><p><b>METHODS</b>We retrospectively analyzed the clinical and follow-up data about 20 cases of PMMT and reviewed the literature relevant to the diagnosis, treatment, and prognosis of the disease.</p><p><b>RESULTS</b>Based on the results of pathology and immunohistochemistry, the 20 PMMT cases included leiomyosarcoma (n = 7), rhabdomyosarcoma (n = 5), prostatic stromal sarcoma (n = 3), chondrosarcoma (n = 1), and undifferentiated PMMT (n = 4). Twelve of the patients were treated by radical prostatectomy (3 concurrently by sigmoid colostomy and 1 by cystostomy), 2 by pelvic tumor resection following arterial embolization, 1 by total pelvic exenteration, 1 by colostomy with pelvic lymph node biopsy, and 4 by conservative therapy because of metastasis to the lung, pelvis and bone. Of the 20 patients, 9 died of systemic metastasis within 3 months after treatment, 3 died at 6, 7, and 14 months, respectively, 3 survived with tumor for 5, 11, and 12 months, respectively, 2 survived without tumor for 12 and 24 months so far, all subjected to periodic chemotherapy postoperatively, and 3 lost to follow-up.</p><p><b>CONCLUSION</b>PMMT is a tumor of high malignancy and rapid progression, for which transrectal ultrasound-guided biopsy remains the main diagnostic method. The clinical stage of the tumor is an important factor influencing its prognosis and the survival rate of the patients can be improved by early diagnosis and combined therapy dominated by radical prostatectomy.</p>
Subject(s)
Humans , Male , Combined Modality Therapy , Methods , Immunohistochemistry , Mesenchymoma , Mortality , Pathology , Therapeutics , Prognosis , Prostatectomy , Prostatic Neoplasms , Mortality , Pathology , Therapeutics , Retrospective StudiesABSTRACT
Eleven recently completed toxicological studies were critically reviewed to identify toxicologically significant endpoints and dose-response information. Dose-response data were compiled and entered into the USEPA's benchmark dose software (BMDS) for calculation of a benchmark dose (BMD) and a benchmark dose low (BMDL). After assessing 91 endpoints across the nine studies, a total of 23 of these endpoints were identified for BMD modeling, and BMDL estimates corresponding to various dose-response models were compiled for these separate endpoints. Thyroid, neurobehavior and reproductive endpoints for BDE-47, -99, -209 were quantitatively evaluated. According to methods and feature of each study, different uncertainty factor (UF) value was decided and subsequently reference doses (RfDs) were proposed. Consistent with USEPA, the lowest BMDLs of 2.10, 81.77, and 1698 µg/kg were used to develop RfDs for BDE-47, -99, and -209, respectively. RfDs for BDE-99 and BDE-209 were comparable to EPA results, and however, RfD of BDE-47 was much lower than that of EPA, which may result from that reproductive/developmental proves to be more sensitive than neurobehavior for BDE-47 and the principal study uses very-low-dose exposure.
Subject(s)
Animals , Female , Male , Mice , Rats , Halogenated Diphenyl Ethers , Toxicity , Reference Standards , Toxicity TestsABSTRACT
This study investigated the growth-regulating effects of progesterone(Prog)on nPR-negative malignant melanoma cells and the possible mechanisms.A375 and A875 cells were cultured and treated with Prog of different concentrations.For signal transduction pathway studies,the cells were pretreated with Prog receptor antagonist(RU486,1×10 7 mol/L)or MAPK inhibitor (U0126,5×10-6 mol/L)for 1 h and then co-incubated with prog(10-9 mol/L)for another 24 h.Indirect immunofluorescence assay,MTT,flow cytornetry and Western blotting were used for assessing the nPR expression,cell growth,cell apoptosis and ERK1/2 Phosphorylation,respectively.Our results showed that lower progesterone concentration promoted the proliferation of both A375 and A875 cells,but this growth-stimulatory effect decreased at progesterone concentration of 1 × 10-7mol/L or higher.The response could be abolished by MAPK inhibitor U0126,but could not be blocked by progesterone antagonist RU486.Flow cytometry exhibited that high concentration(≥1×10-7 mol/L)progesterone increased the apoptosis of the two cells in a dose-dependent manner.The level of ERK 1/2 phosphorylation was increased by a lower progesterone concentration,but reduced by a higber concentration(1×10-6 mol/L).These results suggest progesterone exerts growth-regulating effects on nPR-negative tumor cells through a non-genomic mechanism.
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the clinical presentation pathologic characteristics, diagnosis and treatment of cystadenoma of the seminal vesicle.</p><p><b>METHODS</b>One case of cystadenoma of the seminal vesicle was analyzed and relevant literature reviewed.</p><p><b>RESULT</b>The patient underwent surgical removal of the right seminal vesicle along with the tumor, which was pathologically confirmed to be cystadenoma of the seminal vesicle. Ultrasonography and CT scanning revealed no recurrence 3 months later.</p><p><b>CONCLUSION</b>Cystadenoma of the seminal vesicle is extremely rare and easily missed in diagnosis. Routine digital rectal examination (DRE) is necessary and ultrasonography and CT scan are helpful to diagnosis. Seminal vesiculectomy with tumor removal is an ideal option with good prognosis.</p>